New Safety Information on Diabetes Drug Rosiglitazone

FDA is aware of a potential safety issue related to Avandia (rosiglitazone), a drug approved to treat type 2 diabetes. Concerns are being raised about a possible increased chance of heart attack and heart-related deaths in patients taking ...